Latest Updates
-
Samantha Ruth Prabhu Announces Pregnancy at Maa Inti Bangaaram Success Meet -
World Vitiligo Day 2026: Fighting Stigma And 13 Foods To Avoid According To An Ayurveda Expert -
Quick Healthy Morning Oats Upma Recipe: Your New Go-To Breakfast -
Nirjala Ekadashi 2026: Date, Muhurat, Significance, Rituals, and What to Donate -
Horoscope for Today Jun 25, 2026 - Steady Steps, Calm Progress -
Spicy South Indian Style Pepper Chicken Recipe: A Flavorful Dinner -
‘Skinny but Unhealthy’: The Hidden Problem of Normal Weight Obesity -
Delhi Street Chatpata Papdi Chaat Recipe: Your Ultimate Guide -
Planning for a Baby? Expert Warns Overlooking This Crucial First Step -
90s to Y2K: The Bollywood Lehengas We Never Stopped Dreaming About
Biological E Ltd To Get mRNA Technology From WHO To Produce Covid-19 Vaccines
City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation.

A press release from BE Limited said the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, as a recipient of mRNA (ribonucleic acid) technology from the global health body's technology transfer hub.
Mahima Datla, Managing Director, BE Ltd said: "BE has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next-generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide.''
WHO and their partners will work with the Indian government and Biological E to develop a roadmap and put in place the necessary training and support for the vaccine maker to start producing mRNA vaccines as soon as possible.
Primarily set up to address the COVID-19 emergency, the WHO mRNA technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities.
mRNA vaccines use a messenger RNA created in a laboratory to teach the human cells how to produce a protein that in turn initiates an immune response inside the body against a particular disease. The immune response will fight the actual virus as it gets into the body.
At present, India has no COVID-19 vaccine made on an mRNA platform.
Last month, the Centra had given approval for Biological E's Corbevax to be administered to the 12-14 years age group across the country.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications